Medtronic HMS PLUS Gebrauchsanweisung Seite 180

PN 86506001 Rev. 3.0
86509001_Rev2.book Page 4 Friday, November 14, 2008
Literatur
9-4 HMS Plus Gebrauchsanweisung
9:46 AM
Hill AG, Lefrak EA. Monitoring heparin and protamine therapy during
cardiopulmonary bypass procedures. AMSECT Proc. 1978:6:8.
Horkay F, Martin P, Rajah SM, Walker DR. Response to heparinization in
adults and children undergoing cardiac operations. Ann Thorac Surg.
1992;53:822.
Kemna GD, Bowie JE. Heparin protamine management for cardiopulmonary
bypass patients with abnormal heparin dose response. Proc Am Acad
Cardiovasc Perfus. 1985;6:89.
Kopriva CJ, Spreenivasan N, Stefansson S, Farrell DT, Shaffer WB, Geha
AS. Hypothermia can cause errors in activated coagulation time.
Anesthesiology. 1980;53(3):S85.
Lefemine AA, Lewis M. Activated clotting time for control of anticoagulation
during surgery. Am Surg. 1985;51:274.
Lindblad B, Borgstrom A, Wakefield TW, Whitehouse WM, Stanley JC.
Haemodynamic and haematologic alterations with protamine reversal of
anticoagulation: Comparison of standard heparin and a low molecular weight
heparin fragment. Eur J Vasc Surg. 1987;1:181.
Mochizuki T, Olson PJ, Ramsay JG, Szlam F, Levy JH. Does protamine
reversal affect platelet function? Anesth Analg. 1997:84 SCA 35.
Mochizuki T, Olson PJ, Ramsay JG, Szlam F, Levy JH. Does excess protamine
reversal of heparin affect coagulation after cardiopulmonary bypass? Anesth
Analg. 1997:84:36.
Moorthy S, Pond W. Severe circulatory shock following protamine (an
anaphylactic reaction). Anesth Analg. 1980;59:77.
Niinikoski J, Laato M, Eaaksonen V, Jalonen J, Inberg MV. Use of activated
clotting time to monitor anticoagulation during cardiopulmonary bypass. J
Thorac Cardiovasc Surg. 1984;81:378.
Pifarre R, Babka R, Sullivan HJ, Montoya A, Bakos M, El Etr A. Management
of postoperative heparin rebound following cardiopulmonary bypass. J Thorac
Cardiovasc Surg. 1981;81:378.
Saleem A, Shenaq SS, Yawn DH, Harshberger K, Dienumsch P, Mohindra P.
Heparin monitoring during cardiopulmonary bypass. Ann Clin Lab Sci.
1984;14:474.
Schlueter AJ, Pennell BJ, Olson JD. Evaluation of a new protamine titration
method to assay heparin in whole blood and plasma. Am J Clin Path.
1997;107:511.
Thomas SJ, Gitel SN, Starr NJ, Culliford AT, Wessler S. Activated clotting
time and heparin levels during hypothermic cardiopulmonary bypass.
Anesthesiology. 1981;53:S115.
1 Part# 86509001 Rev 2.0